ISIN | CH0590186661 |
---|---|
Valor Number | 59018666 |
Bloomberg Global ID | SPISI SW |
Fund Name | UBS ETF (CH) - SPI® ESG (CHF) A-acc |
Fund Provider |
UBS Fund Management (Switzerland) AG
Basel, Switzerland Phone: +41 61 288 75 01 E-Mail: sh-ubs-funds-feedback@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Fund Management (Switzerland) AG |
Representative in Switzerland | |
Distributor(s) |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Asset Class | Equities |
EFC Category | Equity Switzerland |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | n/a |
Peculiarities |
Current Price * | 15.79 CHF | 13.09.2024 |
---|---|---|
Previous Price * | 15.71 CHF | 12.09.2024 |
52 Week High * | 16.27 CHF | 02.09.2024 |
52 Week Low * | 13.22 CHF | 27.10.2023 |
NAV * | 15.79 CHF | 13.09.2024 |
Issue Price * | 15.79 CHF | 13.09.2024 |
Redemption Price * | 15.79 CHF | 13.09.2024 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 1,166,460,011 | |
Unit/Share Assets *** | 1,166,460,011 | |
Trading Information SIX |
YTD Performance | +10.63% |
29.12.2023 - 13.09.2024
29.12.2023 13.09.2024 |
---|---|---|
1 month | +1.25% |
13.08.2024 - 13.09.2024
13.08.2024 13.09.2024 |
3 months | 0.00% |
13.06.2024 - 13.09.2024
13.06.2024 13.09.2024 |
6 months | +4.32% |
13.03.2024 - 13.09.2024
13.03.2024 13.09.2024 |
1 year | +12.08% |
13.09.2023 - 13.09.2024
13.09.2023 13.09.2024 |
2 years | +16.72% |
13.09.2022 - 13.09.2024
13.09.2022 13.09.2024 |
3 years | +5.13% |
13.09.2021 - 13.09.2024
13.09.2021 13.09.2024 |
5 years | +23.53% |
23.02.2021 - 13.09.2024
23.02.2021 13.09.2024 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Novartis AG Registered Shares | 13.26% | |
---|---|---|
Roche Holding AG | 12.60% | |
Nestle SA | 10.96% | |
ABB Ltd | 5.60% | |
Zurich Insurance Group AG | 5.58% | |
Compagnie Financiere Richemont SA Class A | 4.25% | |
UBS Group AG | 3.75% | |
Alcon Inc | 3.14% | |
Swiss Re AG | 2.86% | |
Sika AG | 2.81% | |
Last data update | 11.09.2024 |
TER | 0.15% |
---|---|
TER date | 30.06.2023 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.15% |
Ongoing Charges *** | 0.15% |
SRRI ***
|
|
SRRI date *** | 31.08.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |